Then, in contrast to previous efforts that have employed pathologist-derived scores for classification [6, 21], this study uniquely employed cutting edge ML technology to accurately identify every individual tau aggregate in the white matter of AD, PSP, and CBD cases, dissect and quantify morphological features of these aggregates, and identify disease-specific signatures. The gene discussed is MAPT; the disease is Alzheimer disease.